Nilsson J - Search Results

1

The direct Myc target Pim3 cooperates with other Pim kinases in supporting viability of Myc-induced B-cell lymphomas.

Forshell LP, Li Y, Forshell TZ, Rudelius M, Nilsson L, Keller U, Nilsson J. Forshell LP, et al. Among authors: nilsson j, nilsson l. Oncotarget. 2011 Jun;2(6):448-60. doi: 10.18632/oncotarget.283. Oncotarget. 2011. PMID: 21646687 Free PMC article.

2

c-Myc augments gamma irradiation-induced apoptosis by suppressing Bcl-XL.

Maclean KH, Keller UB, Rodriguez-Galindo C, Nilsson JA, Cleveland JL. Maclean KH, et al. Mol Cell Biol. 2003 Oct;23(20):7256-70. doi: 10.1128/MCB.23.20.7256-7270.2003. Mol Cell Biol. 2003. PMID: 14517295 Free PMC article.

3

Mnt loss triggers Myc transcription targets, proliferation, apoptosis, and transformation.

Nilsson JA, Maclean KH, Keller UB, Pendeville H, Baudino TA, Cleveland JL. Nilsson JA, et al. Mol Cell Biol. 2004 Feb;24(4):1560-9. doi: 10.1128/MCB.24.4.1560-1569.2004. Mol Cell Biol. 2004. PMID: 14749372 Free PMC article.

4

Id2 is dispensable for myc-induced lymphomagenesis.

Nilsson JA, Nilsson LM, Keller U, Yokota Y, Boyd K, Cleveland JL. Nilsson JA, et al. Cancer Res. 2004 Oct 15;64(20):7296-301. doi: 10.1158/0008-5472.CAN-04-2133. Cancer Res. 2004. PMID: 15492249

5

Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation.

Nilsson JA, Keller UB, Baudino TA, Yang C, Norton S, Old JA, Nilsson LM, Neale G, Kramer DL, Porter CW, Cleveland JL. Nilsson JA, et al. Cancer Cell. 2005 May;7(5):433-44. doi: 10.1016/j.ccr.2005.03.036. Cancer Cell. 2005. PMID: 15894264 Free article.

6

Nfkb 1 is dispensable for Myc-induced lymphomagenesis.

Keller U, Nilsson JA, Maclean KH, Old JB, Cleveland JL. Keller U, et al. Oncogene. 2005 Sep 15;24(41):6231-40. doi: 10.1038/sj.onc.1208779. Oncogene. 2005. PMID: 15940251

7

Ink4c is dispensable for tumor suppression in Myc-induced B-cell lymphomagenesis.

Nilsson LM, Keller UB, Yang C, Nilsson JA, Cleveland JL, Roussel MF. Nilsson LM, et al. Among authors: nilsson ja. Oncogene. 2007 May 3;26(20):2833-9. doi: 10.1038/sj.onc.1210104. Epub 2006 Nov 13. Oncogene. 2007. PMID: 17099725

8

Myc targets Cks1 to provoke the suppression of p27Kip1, proliferation and lymphomagenesis.

Keller UB, Old JB, Dorsey FC, Nilsson JA, Nilsson L, MacLean KH, Chung L, Yang C, Spruck C, Boyd K, Reed SI, Cleveland JL. Keller UB, et al. EMBO J. 2007 May 16;26(10):2562-74. doi: 10.1038/sj.emboj.7601691. Epub 2007 Apr 26. EMBO J. 2007. PMID: 17464290 Free PMC article.

9

Myc sensitizes p53-deficient cancer cells to the DNA-damaging effects of the DNA methyltransferase inhibitor decitabine.

Höglund A, Nilsson LM, Forshell LP, Maclean KH, Nilsson JA. Höglund A, et al. Blood. 2009 Apr 30;113(18):4281-8. doi: 10.1182/blood-2008-10-183475. Epub 2009 Jan 29. Blood. 2009. PMID: 19179467 Free article.

10

Chemoprevention of B-cell lymphomas by inhibition of the Myc target spermidine synthase.

Forshell TP, Rimpi S, Nilsson JA. Forshell TP, et al. Cancer Prev Res (Phila). 2010 Feb;3(2):140-7. doi: 10.1158/1940-6207.CAPR-09-0166. Epub 2010 Jan 26. Cancer Prev Res (Phila). 2010. PMID: 20103729

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,342 results

Search Page

Filters